Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct market forces, ranging from supply issues to financial constraints. In its latest quarterly report, released on Wednesday (October 30), Eli Lilly missed on sales expectations for Zepbound, its popular weight-loss…
Wall Street had a mixed week, with indexes rising early in the week but closing lower on Thursday (October…
Astral Resources NL (ASX: AAR) (Astral or the Company) is pleased to report an updated JORC compliant (2012 Edition)…
The company is strategically positioned to capitalize on the growing demand for these valuable resources driven by several key…
Mining giant BHP (ASX:BHP,NYSE:BHP,LSE:BHP) and Toyota Australia are set to complete a trial for the first battery-electric HiLux double-cab…
Argyle Resources (CSE:ARGL,OTCQB:ARLYF) released an update about its pilot processing facility in St-Lambert-de-Lauzon, Québec, as it prepares for exploration…
Gold is known as an attractive safe-haven investment and has been used to store wealth during volatile times through…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) fell 2.87 percent on the week to close at 603.95 on Friday (November…
Apple (NASDAQ:AAPL), Amazon (NASDAQ:AMZN) and Intel (NASDAQ:INTC) released their latest quarterly results this week, revealing a mixed bag as…